HomeNew PostsPopularJohn LaMattina, ContributorI cover news on drugs and R&D in the pharma industry

PHARMA & HEALTHCARE

8/07/2013 @ 8:48AM |3,422 views

Is The FDA Being Compromised By Pharma Payments?

SHARE:     In touting an upcoming special issue of theJournal of Law, Medicine and Ethics (JLME), Donald W. Light of the School of Public Health, University of Medicine & Dentistry of NJ, wrote an article entitled “Risky Drugs: Why The FDA Cannot Be Trusted”. Last week I discussed one aspect of this article, Light’s challenge that 90% of FDA approved drugs of the last 30 years are no more effective than existing drugs. However, the bulk of his essay focuses not on his views about pharma’s competence but rather on his issues with the FDA. While I found a number of his comments troubling, the following stood out.

continue to read here